老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagenic Therapeutics Inc

1.62
-0.0300-1.82%
盤後：1.58-0.0398-2.46%19:57 EST
成交量：56.44萬
成交額：94.97萬
市值：313.45萬
市盈率：-0.12
高：1.65
開：1.61
低：1.46
收：1.65
52周最高：14.28
52周最低：1.46
股本：193.49萬
流通股本：191.49萬
量比：5.32
換手率：29.47%
股息：- -
股息率：- -
每股收益(TTM):-13.0507
每股收益(LYR):-15.7868
淨資產收益率：-512.79%
總資產收益率：-189.60%
市淨率：-35.49
市盈率(LYR):-0.10

資料載入中...

總覽公司新聞資訊公告
2022/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/07

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/05

重要事件披露

8-K - Current report
2021/10/01

重要事件披露

8-K - Current report
2021/09/14

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/19

重要事件披露

8-K - Current report
2021/08/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/26

重要事件披露

8-K - Current report
2021/07/02

重要事件披露

8-K - Current report
2021/06/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/17

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

重要事件披露

8-K - Current report
2021/04/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/23

SEC問詢函

CORRESP [Cover] - Correspondence
更多